Atnaujinkite slapukų nuostatas

Potency Testing of Veterinary Vaccines for Animals: The Way from in Vivo to in Vitro: International Scientific Workshop, Langen, December 2010: Proceedings [Minkštas viršelis]

  • Formatas: Paperback / softback, 164 pages, weight: 348 g, 36, 36 fig., 10 tab.
  • Serija: Developments in Biologicals 134
  • Išleidimo metai: 02-Jul-2012
  • Leidėjas: S Karger AG
  • ISBN-10: 3805598920
  • ISBN-13: 9783805598927
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 164 pages, weight: 348 g, 36, 36 fig., 10 tab.
  • Serija: Developments in Biologicals 134
  • Išleidimo metai: 02-Jul-2012
  • Leidėjas: S Karger AG
  • ISBN-10: 3805598920
  • ISBN-13: 9783805598927
Kitos knygos pagal šią temą:
The International Scientific Workshop on "Potency Testing of Veterinary Vaccines for Animals: The Way From in Vivo to in Vitro, was held in Langen, Germany in December 2010". Before being placed on the market, inactivated vaccines are predominantly tested in vivo, mainly in laboratory animals. In recent years substantial efforts have been made either to modify these animal tests in order to reduce the number of required animals and the stress imposed on them (Refinement) or to completely replace these experiments by in vitro tests. The acceptance of these tests differs considerably among vaccine manufacturers and licensing authorities. It is thus understandable that vaccines manufacturers hesitate to adopt the new test methods. This international scientific workshop aimed to promote further progress. It was attended by more than 130 participants from industry, academia and regulatory authorities from some 22 countries around the world. The current state of knowledge of replacement of in vivo tests was recapitulated, including examples of its successful implementation as well as still existing hurdles. Advantages and disadvantages of existing replacement approaches were presented and discussed. Proposals for new ways to ensure the quality of veterinary immunology medicinal products (IVMPs) were made. The hurdles to be overcome whenever the 3Rs should be implemented in the potency testing of inactivated veterinary vaccines were identified and discussed and a proposal for a road map for future steps towards in vitro testing was made.
Preface ix
C. Jungback
Session I Use of the 3R Approach for Potency (1)
1(34)
Introduction: History, Approaches, Legal Situation and Political Pressure, Outlook, Expectations
3(6)
J.-M. Spieser
Recent Progress and Future Directions for Reduction, Refinement, and Replacement of Animal Use in Veterinary Vaccine Potency and Safety Testing: A Report from the 2010 NICEATM ICCVAM International Vaccine Workshop
9(14)
W.S. Stokes
J. Kulpa-Eddy
K. Brown
G. Srinivas
R. McFarland
Potency Testing of Inactivated Rabies Vaccines Using a Serological Method
23(6)
E. Kamphuis
B. Kramer
H. Schildger
K. Duchow
Potency Testing of Veterinary Rabies Vaccines: Replacement of Challenge by in Vitro Testing: Considerations for Development of Alternative Assays
29(6)
C.E. Lewis
A.M. Fry
J.R. Hermann
D. Siev
D.M. Dusek
D.M. Gatewood
Session II Use of the 3R Approach for Potency (2)
35(32)
Towards in Vitro Potency Testing of Inactivated Erysipelas Vaccines
37(8)
E. Balks
C. Wolf
H. Loessner
E. Werner
Testing of Veterinary Clostridial Vaccines: From Mouse to Microtitre Plate
45(6)
K. Redhead
K. Wood
K. Jackson
The Quantitative ELISA for Inactivated Newcastle Disease Virus Antigen: Development of the Test System and the Way to a Ph. Eur in Vitro Potency Test
51(4)
H.L. Oei
The Quantitative ELISA for Inactivated Newcastle Antigen: Experience Report From an OMCL
55(12)
A. Motitschke
C. Jungback
Session III In Vivo / in Vitro, a Critical Analysis
67(46)
The Validation of Potency Tests: Hurdles Identified by EMA/CVMP/IWP
69(6)
R. Woodland
In Vitro Vaccine Potency Testing: A Proposal for Reducing Animal Use for Requalification Testing
75(8)
K. Brown
W.S. Stokes
In Vitro Antigen Measurement and Potency Tests: Challenges Encountered During Method Development... and Lessons Learned
83(10)
V. Kubiak
In Vitro Potency Tests: Challenges Encountered During Method Development
93(8)
C. Yomayuza
H.J. Thiel
M. Konig
Successful Development and Validation of an in Vitro Replacement Assay for Leptospira Vaccine Potency Tests
101(6)
J. Kulpa-Eddy
AlphaLISA Assays to Improve the Vaccine Development Process
107(6)
G. Cosentino
Session IV Consistency as an Alternative to Potency
113(36)
Consistency as Tool to Support in Vitro Batch Potency Testing in GMP Production
115(4)
C. Stirling
Consistency as an Alternative to Potency Testing
119(4)
K. Duchow
Human Adenovirus-Vectored Foot-and-Mouth Disease Vaccines: Establishment of a Vaccine Product Profile Through in Vitro Testing
123(12)
D. Brake
M. McLihaney
T. Miller
K. Christianson
A. Keene
G. Lohnas
C. Purcell
J. Neilan
C. Schutta
J. Barrera
T. Burrage
D.E. Brough
B.T. Butman
Potential Application of the Consistency Approach for Vaccine Potency Testing
135(6)
J. Arciniega
L.A. Sirota
Appropriateness of in Vitro Potency Tests or Consistency Tests for Vaccine Stability Studies
141(8)
M.-A. Pfannenstiel
M. Inman
Workshop Summary 149(4)
Workshop presentations not in this publication 153(2)
Participants 155(4)
Index of Authors 159(2)
Developments in Biological Standardization 161(2)
Developments in Biologicals 163